Cargando…
Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies
Advanced therapy medicinal products (ATMPs) are medicines for human use based on genes, cells or tissue engineering. After clear successes in adults, the nascent technology now sees increasing pediatric application. For many still untreatable disorders with pre- or perinatal onset, timely interventi...
Autores principales: | Lederer, Carsten W., Koniali, Lola, Buerki-Thurnherr, Tina, Papasavva, Panayiota L., La Grutta, Stefania, Licari, Amelia, Staud, Frantisek, Bonifazi, Donato, Kleanthous, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031205/ https://www.ncbi.nlm.nih.gov/pubmed/35456627 http://dx.doi.org/10.3390/pharmaceutics14040793 |
Ejemplares similares
-
Therapy Development by Genome Editing of Hematopoietic Stem Cells
por: Koniali, Lola, et al.
Publicado: (2021) -
Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
por: Papasavva, Panayiota, et al.
Publicado: (2019) -
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
por: Papaioannou, Nikoletta Y., et al.
Publicado: (2023) -
Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI−110 (G > A)) β-Thalassemia
por: Patsali, Petros, et al.
Publicado: (2020) -
CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation
por: Papasavva, Panayiota L., et al.
Publicado: (2022)